{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T16:30:28Z","timestamp":1788280228909,"version":"build-2803163510"},"reference-count":117,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2021,10,15]],"date-time":"2021-10-15T00:00:00Z","timestamp":1634256000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Oncol."],"abstract":"<jats:p>During the last few decades, pediatric acute lymphoblastic leukemia (ALL) cure rates have improved significantly with rates exceeding 90%. Parallel to this remarkable improvement, there has been mounting interest in the long-term health of the survivors. Consequently, modified treatment protocols have been developed and resulted in the reduction of many adverse long-term consequences. Nevertheless, these are still substantial concerns that warrant further mitigation efforts. In the current review, pediatric-ALL survivors\u2019 late adverse events, including secondary malignant neoplasms (SMNs), cardiac toxicity, neurotoxicity, bone toxicity, hepatic dysfunction, visual changes, obesity, impact on fertility, and neurocognitive effects have been evaluated. Throughout this review, we attempted to answer a fundamental question: can the recent molecular findings mitigate pediatric-ALL chemotherapy\u2019s long-term sequelae on adult survivors? For SMNs, few genetic predisposition factors have been identified including <jats:italic>TP53<\/jats:italic> and <jats:italic>POT1<\/jats:italic> variants. Other treatment-related risk factors have been identified such as anthracyclines\u2019 possible association with breast cancer in female survivors. Cardiotoxicity is another significant and common adverse event with some germline variants been found, albeit with conflicting evidence, to increase the risk of cardiac toxicity. For peripheral neurotoxicity, vincristine is the primary neurotoxic agent in ALL regimens. Some germline genetic variants were found to be associated with the vincristine neurotoxic effect\u2019s vulnerability. However, these were mainly detected with acute neuropathy. Moreover, the high steroid doses and prolonged use increase bone toxicity and obesity risk with some pharmacogenetic biomarkers were associated with increased steroid sensitivity. Therefore, the role of these biomarkers in tailoring steroid choice and dose is a promising research area. Future directions in pediatric ALL treatment should consider the various opportunities provided by genomic medicine. Understanding the molecular bases underlying toxicities will classify patients into risk groups and implement a closer follow-up to those at higher risk. Pharmacogenetic-guided dosing and selecting between alternative agents have proven their efficacy in the short-term management of childhood ALL. It is the right time to think about a similar approach for the life-long consequences on survivors.<\/jats:p>","DOI":"10.3389\/fonc.2021.710163","type":"journal-article","created":{"date-parts":[[2021,10,16]],"date-time":"2021-10-16T02:03:01Z","timestamp":1634349781000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":51,"title":["Long-Term Effects of Pediatric Acute Lymphoblastic Leukemia Chemotherapy: Can Recent Findings Inform Old Strategies?"],"prefix":"10.3389","volume":"11","author":[{"given":"Zeina N.","family":"Al-Mahayri","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammad M.","family":"AlAhmad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bassam R.","family":"Ali","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2021,10,15]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.3324\/haematol.2020.247031","article-title":"Pediatric Acute Lymphoblastic Leukemia","volume":"105","author":"Inaba","year":"2020","journal-title":"Haematologica"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.20.00493","article-title":"Reduced Morbidity and Mortality in Survivors of Childhood Acute Lymphoblastic Leukemia: A Report From the Childhood Cancer Survivor Study","volume":"38","author":"Dixon","year":"2020","journal-title":"J Clin Oncol"},{"key":"B3","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1038\/nrc3634","article-title":"Survivors of Childhood and Adolescent Cancer: Life-Long Risks and Responsibilities","volume":"14","author":"Robison","year":"2014","journal-title":"Nat Rev Cancer"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2009.22.3339","article-title":"The Childhood Cancer Survivor Study: A National Cancer Institute-Supported Resource for Outcome and Intervention Research","volume":"27","author":"Robison","year":"2009","journal-title":"J Clin Oncol"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(18)30537-0","article-title":"Temporal Patterns in the Risk of Chronic Health Conditions in Survivors of Childhood Cancer Diagnosed 1970-99: A Report From the Childhood Cancer Survivor Study Cohort","volume":"19","author":"Gibson","year":"2018","journal-title":"Lancet Oncol"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2004.11.032","article-title":"Development of Risk-Based Guidelines for Pediatric Cancer Survivors: The Children\u2019s Oncology Group Long-Term Follow-Up Guidelines From the Children\u2019s Oncology Group Late Effects Committee and Nursing Discipline","volume":"22","author":"Landier","year":"2004","journal-title":"J Clin Oncol"},{"key":"B7","doi-asserted-by":"publisher","first-page":"1","DOI":"10.4274\/tjh.galenos.2018.2018.0150","article-title":"Late Effects of Therapy in Childhood Acute Lymphoblastic Leukemia Survivors","volume":"36","author":"K\u0131z\u0131locak","year":"2019","journal-title":"Turk J Haematol"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1002\/ijc.22827","article-title":"New Malignancies Following Childhood Cancer in the United States, 1973-2002","volume":"121","author":"Inskip","year":"2007","journal-title":"Int J Cancer"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1016\/j.canep.2020.101711","article-title":"Cumulative Burden of Subsequent Neoplasms, Cardiovascular and Respiratory Morbidity in Young People Surviving Cancer","volume":"66","author":"Smith","year":"2020","journal-title":"Cancer Epidemiol"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-16-0610","article-title":"Somatic and Germline TP53 Alterations in Second Malignant Neoplasms From Pediatric Cancer Survivors","volume":"23","author":"Sherborne","year":"2017","journal-title":"Clin Cancer Res"},{"key":"B11","doi-asserted-by":"publisher","first-page":"7","DOI":"10.21037\/ace-2020-01","article-title":"The Burden of Second Primary Cancers Among Childhood Cancer Survivors","volume":"4","author":"Abrah\u00e3o","year":"2020","journal-title":"Ann Cancer Epidemiol"},{"key":"B12","doi-asserted-by":"publisher","first-page":"130","DOI":"10.3390\/children6120130","article-title":"Large Population Analysis of Secondary Cancers in Pediatric Leukemia Survivors","volume":"6","author":"Yavvari","year":"2019","journal-title":"Children"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2012.47.0500","article-title":"Second Malignant Neoplasms After Treatment of Childhood Acute Lymphoblastic Leukemia","volume":"31","author":"Schmiegelow","year":"2013","journal-title":"JCO"},{"key":"B14","doi-asserted-by":"publisher","first-page":"3480","DOI":"10.3390\/ijms19113480","article-title":"Anthracyclines as Topoisomerase II Poisons: From Early Studies to New Perspectives","volume":"19","author":"Marinello","year":"2018","journal-title":"Int J Mol Sci"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2017.76.7764","article-title":"Risk, Risk Factors, and Surveillance of Subsequent Malignant Neoplasms in Survivors of Childhood Cancer: A Review","volume":"36","author":"Turcotte","year":"2018","journal-title":"J Clin Oncol"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1080\/23808993.2018.1517026","article-title":"The Genetic Risk of Second Cancers: Should the Therapy for Acute Lymphoblastic Leukemia be Individualized According to Germline Genetic Makeup","volume":"3","author":"Felton","year":"2018","journal-title":"Expert Rev Precis Med Drug Dev"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2017.75.5215","article-title":"TP53 Germline Variations Influence the Predisposition and Prognosis of B-Cell Acute Lymphoblastic Leukemia in Children","volume":"36","author":"Qian","year":"2018","journal-title":"J Clin Oncol"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0228887","article-title":"Genetic Variation in POT1 and Risk of Thyroid Subsequent Malignant Neoplasm: A Report From the Childhood Cancer Survivor Study","volume":"15","author":"Richard","year":"2020","journal-title":"PloS One"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2015.62.3314","article-title":"Breast Cancer Risk in Childhood Cancer Survivors Without a History of Chest Radiotherapy: A Report From the Childhood Cancer Survivor Study","volume":"34","author":"Henderson","year":"2016","journal-title":"J Clin Oncol"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2016.71.6902","article-title":"Long-Term Risk of Subsequent Malignant Neoplasms After Treatment of Childhood Cancer in the DCOG LATER Study Cohort: Role of Chemotherapy","volume":"35","author":"Teepen","year":"2017","journal-title":"J Clin Oncol"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2017.76.3920","article-title":"Cardiovascular Disease in Survivors of Childhood Cancer: Insights Into Epidemiology, Pathophysiology, and Prevention","volume":"36","author":"Armenian","year":"2018","journal-title":"J Clin Oncol"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.l6794","article-title":"Major Cardiac Events for Adult Survivors of Childhood Cancer Diagnosed Between 1970 and 1999: Report From the Childhood Cancer Survivor Study Cohort","volume":"368","author":"Mulrooney","year":"2020","journal-title":"BMJ"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.23534","article-title":"Genetic Polymorphisms in the Carbonyl Reductase 3 Gene CBR3 and the NAD(P)H:quinone Oxidoreductase 1 Gene NQO1 in Patients Who Developed Anthracycline-Related Congestive Heart Failure After Childhood Cancer","volume":"112","author":"Blanco","year":"2008","journal-title":"Cancer"},{"key":"B24","doi-asserted-by":"publisher","first-page":"394","DOI":"10.1200\/JCO.2014.56.1373","article-title":"Individual Prediction of Heart Failure Among Childhood Cancer Survivors","volume":"33","author":"Chow","year":"2015","journal-title":"J Clin Oncol"},{"key":"B25","doi-asserted-by":"publisher","first-page":"2885","DOI":"10.3390\/jcm9092885","article-title":"Management of Cardiac Toxicity Induced by Chemotherapy","volume":"9","author":"Trapani","year":"2020","journal-title":"J Clin Med"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejphar.2017.10.043","article-title":"Molecular Mechanism of Doxorubicin-Induced Cardiomyopathy - An Update","volume":"818","author":"Renu K","year":"2018","journal-title":"Eur J Pharmacol"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2010.34.3467","article-title":"Pharmacogenomic Prediction of Anthracycline-Induced Cardiotoxicity in Children","volume":"30","author":"Visscher","year":"2012","journal-title":"J Clin Oncol"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1002\/pbc.24505","article-title":"Validation of Variants in SLC28A3 and UGT1A6 as Genetic Markers Predictive of Anthracycline-Induced Cardiotoxicity in Children","volume":"60","author":"Visscher","year":"2013","journal-title":"Pediatr Blood Cancer"},{"key":"B29","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1042\/CBI20110264","article-title":"ABCC1 Polymorphisms in Anthracycline-Induced Cardiotoxicity in Childhood Acute Lymphoblastic Leukaemia","volume":"36","author":"Semsei","year":"2012","journal-title":"Cell Biol Int"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0085982","article-title":"Common Variants on Cytotoxic T Lymphocyte Antigen-4 Polymorphisms Contributes to Type 1 Diabetes Susceptibility: Evidence Based on 58 Studies","volume":"9","author":"Wang","year":"2014","journal-title":"PloS One"},{"key":"B31","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1161\/CIRCULATIONAHA.118.037934","article-title":"Genetic Variants Associated With Cancer Therapy-Induced Cardiomyopathy","volume":"140","author":"Garcia-Pavia","year":"2019","journal-title":"Circulation"},{"key":"B32","doi-asserted-by":"publisher","first-page":"9698","DOI":"10.1038\/s41598-017-09517-2","article-title":"Hypertension Susceptibility Loci Are Associated With Anthracycline-Related Cardiotoxicity in Long-Term Childhood Cancer Survivors","volume":"7","author":"Hildebrandt","year":"2017","journal-title":"Sci Rep"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.1038\/tpj.2015.63","article-title":"Polymorphisms of ABCC5 and NOS3 Genes Influence Doxorubicin Cardiotoxicity in Survivors of Childhood Acute Lymphoblastic Leukemia","volume":"16","author":"Krajinovic","year":"2016","journal-title":"Pharmacogenom J"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.1038\/ng.3374","article-title":"A Coding Variant in RARG Confers Susceptibility to Anthracycline-Induced Cardiotoxicity in Childhood Cancer","volume":"47","author":"Aminkeng","year":"2015","journal-title":"Nat Genet"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2015.63.4550","article-title":"CELF4 Variant and Anthracycline-Related Cardiomyopathy: A Children\u2019s Oncology Group Genome-Wide Association Study","volume":"34","author":"Wang","year":"2016","journal-title":"J Clin Oncol"},{"key":"B36","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1111\/bcp.14628","article-title":"Is There Scope for Better Individualisation of Anthracycline Cancer Chemotherapy","volume":"87","author":"Sallustio","year":"2021","journal-title":"Br J Clin Pharmacol"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.1097\/FPC.0000000000000309","article-title":"Exome Array Analysis Identifies GPR35 as a Novel Susceptibility Gene for Anthracycline-Induced Cardiotoxicity in Childhood Cancer","volume":"27","author":"Ruiz-Pinto","year":"2017","journal-title":"Pharmacogenet Genomics"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.1007\/s10549-017-4497-9","article-title":"Exome Array Analysis Identifies ETFB as a Novel Susceptibility Gene for Anthracycline-Induced Cardiotoxicity in Cancer Patients","volume":"167","author":"Ruiz-Pinto","year":"2018","journal-title":"Breast Cancer Res Treat"},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-20-2675","article-title":"Genetic Variants Associated With Therapy-Related Cardiomyopathy Among Childhood Cancer Survivors of African Ancestry","author":"Sapkota","year":"2020","journal-title":"Cancer Res"},{"key":"B40","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1186\/s40959-019-0054-5","article-title":"Strategies to Prevent Anthracycline-Induced Cardiotoxicity in Cancer Survivors","volume":"5","author":"Bansal","year":"2019","journal-title":"Cardiooncology"},{"key":"B41","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1186\/2162-3619-1-10","article-title":"Comparison of Safety and Toxicity of Liposomal Doxorubicin vs. Conventional Anthracyclines: A Meta-Analysis","volume":"1","author":"Rafiyath","year":"2012","journal-title":"Exp Hematol Oncol"},{"key":"B42","doi-asserted-by":"publisher","DOI":"10.1002\/cphy.c180017","article-title":"Doxorubicin-Induced Cardiomyopathy in Children","volume":"9","author":"Mancilla","year":"2019","journal-title":"Compr Physiol"},{"key":"B43","doi-asserted-by":"publisher","DOI":"10.1002\/pbc.25381","article-title":"Prospective Cardiac MRI for the Analysis of Biventricular Function in Children Undergoing Cancer Treatments","volume":"62","author":"de Ville de Goyet","year":"2015","journal-title":"Pediatr Blood Cancer"},{"key":"B44","doi-asserted-by":"publisher","DOI":"10.3389\/fnmol.2017.00174","article-title":"Pathophysiology of Chemotherapy-Induced Peripheral Neuropathy","volume":"10","author":"Starobova","year":"2017","journal-title":"Front Mol Neurosci"},{"key":"B45","doi-asserted-by":"publisher","DOI":"10.1001\/jamaneurol.2018.0963","article-title":"Chemotherapy-Induced Peripheral Neuropathy in Long-Term Survivors of Childhood Cancer","volume":"75","author":"Kandula","year":"2018","journal-title":"JAMA Neurol"},{"key":"B46","doi-asserted-by":"publisher","DOI":"10.1002\/pbc.26471","article-title":"Vincristine-Induced Peripheral Neuropathy in Survivors of Childhood Acute Lymphoblastic Leukaemia","volume":"64","author":"Tay","year":"2017","journal-title":"Pediatr Blood Cancer"},{"key":"B47","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1111\/jns.12114","article-title":"Patterns and Severity of Vincristine-Induced Peripheral Neuropathy in Children With Acute Lymphoblastic Leukemia","volume":"20","author":"Lavoie Smith","year":"2015","journal-title":"J Peripher Nerv Syst"},{"key":"B48","doi-asserted-by":"publisher","DOI":"10.3389\/fped.2020.526235","article-title":"Polyneuropathy in Acute Lymphoblastic Leukemia Long-Term Survivors: Clinical and Electrophysiological Characteristics With the Impact of Radiotherapy","volume":"8","author":"Kroczka","year":"2021","journal-title":"Front Pediatr"},{"key":"B49","doi-asserted-by":"publisher","DOI":"10.1080\/17425255.2021.1855141","article-title":"Genetic Factors Influencing the Development of Vincristine-Induced Neurotoxicity","volume":"17","author":"Pozzi","year":"2021","journal-title":"Expert Opin Drug Metab Toxicol"},{"key":"B50","doi-asserted-by":"publisher","DOI":"10.1002\/pbc.22845","article-title":"Increased Risk of Vincristine Neurotoxicity Associated With Low CYP3A5 Expression Genotype in Children With Acute Lymphoblastic Leukemia","volume":"56","author":"Egbelakin","year":"2011","journal-title":"Pediatr Blood Cancer"},{"key":"B51","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1177\/1078155214553143","article-title":"The Effect of Race on the CYP3A-Mediated Metabolism of Vincristine in Pediatric Patients With Acute Lymphoblastic Leukemia","volume":"22","author":"Sims","year":"2016","journal-title":"J Oncol Pharm Pract"},{"key":"B52","doi-asserted-by":"publisher","DOI":"10.1111\/bjh.14678","article-title":"Pharmacogenetic Association With Neurotoxicity in Hispanic Children With Acute Lymphoblastic Leukaemia","volume":"181","author":"McClain","year":"2018","journal-title":"Br J Haematol"},{"key":"B53","doi-asserted-by":"publisher","first-page":"10.1002\/pbc.26854","DOI":"10.1002\/pbc.26854","article-title":"CYP3A5 Genotype and Its Impact on Vincristine Pharmacokinetics and Development of Neuropathy in Kenyan Children With Cancer","volume":"65","author":"Skiles","year":"2018","journal-title":"Pediatr Blood Cancer"},{"key":"B54","doi-asserted-by":"publisher","DOI":"10.1002\/cpt.1179","article-title":"Canadian Pharmacogenomics Network for Drug Safety Consortium. Pharmacogenomics of Vincristine-Induced Peripheral Neuropathy Implicates Pharmacokinetic and Inherited Neuropathy Genes","volume":"105","author":"Wright","year":"2019","journal-title":"Clin Pharmacol Ther"},{"key":"B55","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2015.0894","article-title":"Association of an Inherited Genetic Variant With Vincristine-Related Peripheral Neuropathy in Children With Acute Lymphoblastic Leukemia","volume":"313","author":"Diouf","year":"2015","journal-title":"JAMA"},{"key":"B56","doi-asserted-by":"publisher","DOI":"10.1097\/FPC.0000000000000191","article-title":"Lack of Association of the CEP72 Rs924607 TT Genotype With Vincristine-Related Peripheral Neuropathy During the Early Phase of Pediatric Acute Lymphoblastic Leukemia Treatment in a Spanish Population","volume":"26","author":"Gutierrez-Camino","year":"2016","journal-title":"Pharmacogenet Genomics"},{"key":"B57","doi-asserted-by":"publisher","DOI":"10.1002\/cpt.1324","article-title":"Genetic Variants Associated With Vincristine-Induced Peripheral Neuropathy in Two Populations of Children With Acute Lymphoblastic Leukemia","volume":"105","author":"Li","year":"2019","journal-title":"Clin Pharmacol Ther"},{"key":"B58","doi-asserted-by":"publisher","DOI":"10.1097\/MPH.0000000000001529","article-title":"Switching to Bortezomib may Improve Recovery From Severe Vincristine Neuropathy in Pediatric Acute Lymphoblastic Leukemia","volume":"41","author":"Joshi","year":"2019","journal-title":"J Pediatr Hematol Oncol"},{"key":"B59","doi-asserted-by":"publisher","DOI":"10.1542\/peds.2007-1396","article-title":"Bone Mineral Density Deficits in Survivors of Childhood Cancer: Long-Term Follow-Up Guidelines and Review of the Literature","volume":"121","author":"Wasilewski-Masker","year":"2008","journal-title":"Pediatrics"},{"key":"B60","doi-asserted-by":"publisher","DOI":"10.1002\/jbmr.4234","article-title":"Genome-Wide Association Studies Reveal Novel Locus With Sex-\/Therapy-Specific Fracture Risk Effects in Childhood Cancer Survivors","volume":"36","author":"Im","year":"2020","journal-title":"J Bone Miner Res"},{"key":"B61","doi-asserted-by":"publisher","DOI":"10.2217\/pgs-2019-0087","article-title":"Genes Identified Through Genome-Wide Association Studies of Osteonecrosis in Childhood Acute Lymphoblastic Leukemia Patients","volume":"20","author":"Gagn\u00e9","year":"2019","journal-title":"Pharmacogenomics"},{"key":"B62","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2018-027204","article-title":"British OsteoNEcrosis Study (BONES) Protocol: A Prospective Cohort Study to Examine the Natural History of Osteonecrosis in Older Children, Teenagers and Young Adults With Acute Lymphoblastic Leukaemia and Lymphoblastic Lymphoma","volume":"9","author":"Amin","year":"2019","journal-title":"BMJ Open"},{"key":"B63","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.18.01917","article-title":"Prediction of Low and Very Low Bone Mineral Density Among Adult Survivors of Childhood Cancer","volume":"37","author":"van Atteveld","year":"2019","journal-title":"J Clin Oncol"},{"key":"B64","doi-asserted-by":"publisher","DOI":"10.1002\/pbc.25010","article-title":"Bone Mineral Density Among Long-Term Survivors of Childhood Acute Lymphoblastic Leukemia: Results From the St. Jude Lifetime Cohort Study","volume":"61","author":"Gurney","year":"2014","journal-title":"Pediatr Blood Cancer"},{"key":"B65","doi-asserted-by":"publisher","DOI":"10.1002\/pbc.25324","article-title":"Catch-Up of Bone Mineral Density Among Long-Term Survivors of Childhood Cancer? Letter to the Editor: Response to the Article of Gurney Et al., 2014","volume":"62","author":"Pluijm","year":"2015","journal-title":"Pediatr Blood Cancer"},{"key":"B66","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2007-11-123885","article-title":"A PAI-1 (SERPINE1) Polymorphism Predicts Osteonecrosis in Children With Acute Lymphoblastic Leukemia: A Report From the Children\u2019s Oncology Group","volume":"111","author":"French","year":"2008","journal-title":"Blood"},{"key":"B67","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2002-08-2454","article-title":"Dexamethasone Versus Prednisone and Daily Oral Versus Weekly Intravenous Mercaptopurine for Patients With Standard-Risk Acute Lymphoblastic Leukemia: A Report From the Children\u2019s Cancer Group","volume":"101","author":"Bostrom","year":"2003","journal-title":"Blood"},{"key":"B68","doi-asserted-by":"publisher","DOI":"10.1016\/j.phoj.2019.03.002","article-title":"Long Term Effects of Therapy Among Childhood Cancer Survivors Treated in the Last Two Decades","volume":"4","author":"AbdelHameid","year":"2019","journal-title":"Pediatr Hematol Oncol J"},{"key":"B69","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1038\/s41397-017-0002-4","article-title":"Influence of BCL2L11 Polymorphism on Osteonecrosis During Treatment of Childhood Acute Lymphoblastic Leukemia","volume":"19","author":"Plesa","year":"2019","journal-title":"Pharmacogenom J"},{"key":"B70","doi-asserted-by":"publisher","DOI":"10.3324\/haematol.2016.160507","article-title":"Hyperlipidemia is a Risk Factor for Osteonecrosis in Children and Young Adults With Acute Lymphoblastic Leukemia","volume":"102","author":"Mogensen","year":"2017","journal-title":"Haematologica"},{"key":"B71","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.18.01877","article-title":"Intermittent Versus Continuous PEG-Asparaginase to Reduce Asparaginase-Associated Toxicities: A NOPHO ALL2008 Randomized Study","volume":"37","author":"Albertsen","year":"2019","journal-title":"J Clin Oncol"},{"key":"B72","doi-asserted-by":"publisher","DOI":"10.1016\/j.thromres.2013.06.023","article-title":"Relation Between Osteonecrosis of the Femoral Head and PAI-1 4G\/5G Gene Polymorphism: A Meta-Analysis","volume":"8","author":"Zeng","year":"2015","journal-title":"Int J Clin Exp Med"},{"key":"B73","doi-asserted-by":"publisher","DOI":"10.2220\/biomedres.31.281","article-title":"Dexamethasone-Induced Plasminogen Activator Inhibitor-1 Expression in Human Primary Bone Marrow Adipocytes","volume":"31","author":"Hozumi","year":"2010","journal-title":"BioMed Res"},{"key":"B74","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2010-10-311969","article-title":"Pharmacokinetic, Pharmacodynamic, and Pharmacogenetic Determinants of Osteonecrosis in Children With Acute Lymphoblastic Leukemia","volume":"117","author":"Kawedia","year":"2011","journal-title":"Blood"},{"key":"B75","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2015-05-643601","article-title":"Genetics of Glucocorticoid-Associated Osteonecrosis in Children With Acute Lymphoblastic Leukemia","volume":"126","author":"Karol","year":"2015","journal-title":"Blood"},{"key":"B76","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2015-10-673848","article-title":"Genetic Risk Factors for the Development of Osteonecrosis in Children Under Age 10 Treated for Acute Lymphoblastic Leukemia","volume":"127","author":"Karol","year":"2016","journal-title":"Blood"},{"key":"B77","doi-asserted-by":"publisher","DOI":"10.1038\/tpj.2015.92","article-title":"A Genetic Factor Associated With Low Final Bone Mineral Density in Children After a Long-Term Glucocorticoids Treatment","volume":"17","author":"Park","year":"2017","journal-title":"Pharmacogenom J"},{"key":"B78","doi-asserted-by":"publisher","first-page":"1","DOI":"10.6065\/apem.2020.25.1.1","article-title":"Bone Morbidity in Pediatric Acute Lymphoblastic Leukemia","volume":"25","author":"Ahn","year":"2020","journal-title":"Ann Pediatr Endocrinol Metab"},{"key":"B79","doi-asserted-by":"publisher","DOI":"10.1093\/annonc\/mdz120","article-title":"Bone Health in Childhood Cancer: Review of the Literature and Recommendations for the Management of Bone Health in Childhood Cancer Survivors","volume":"30","author":"Marcucci","year":"2019","journal-title":"Ann Oncol"},{"key":"B80","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD008205.pub3","article-title":"Hepatic Late Adverse Effects After Antineoplastic Treatment for Childhood Cancer","volume":"4","author":"Mulder","year":"2019","journal-title":"Cochrane Database Syst Rev"},{"key":"B81","doi-asserted-by":"publisher","first-page":"62","DOI":"10.4103\/0976-500X.184769","article-title":"L-Asparaginase in the Treatment of Patients With Acute Lymphoblastic Leukemia","volume":"7","author":"Egler","year":"2016","journal-title":"J Pharmacol Pharmacother"},{"key":"B82","doi-asserted-by":"publisher","DOI":"10.3109\/10428194.2015.1101098","article-title":"Asparaginase-Associated Toxicity in Children With Acute Lymphoblastic Leukemia","volume":"57","author":"Hijiya","year":"2016","journal-title":"Leuk Lymphoma"},{"key":"B83","doi-asserted-by":"publisher","DOI":"10.1097\/MPH.0000000000000206","article-title":"Mercaptopurine\/Methotrexate Maintenance Therapy of Childhood Acute Lymphoblastic Leukemia: Clinical Facts and Fiction","volume":"36","author":"Schmiegelow","year":"2014","journal-title":"J Pediatr Hematol Oncol"},{"key":"B84","doi-asserted-by":"publisher","DOI":"10.1002\/pbc.22265","article-title":"Hepato-Biliary Late Effects in Survivors of Childhood and Adolescent Cancer: A Report From the Children\u2019s Oncology Group","volume":"54","author":"Castellino","year":"2010","journal-title":"Pediatr Blood Cancer"},{"key":"B85","doi-asserted-by":"publisher","DOI":"10.1002\/pbc.24913","article-title":"Use of Allopurinol in Children With Acute Lymphoblastic Leukemia to Reduce Skewed Thiopurine Metabolism","volume":"61","author":"Brackett","year":"2014","journal-title":"Pediatr Blood Cancer"},{"key":"B86","doi-asserted-by":"publisher","DOI":"10.1002\/cpt.1304","article-title":"Clinical Pharmacogenetics Implementation Consortium (CPIC) Guideline for Thiopurine Dosing Based on TPMT and NUDT15 Genotypes: 2018 Update","volume":"105","author":"Relling","year":"2019","journal-title":"Clin Pharmacol Ther"},{"key":"B87","unstructured":"PharmGKBVery Important Pharmacogene: TPMT"},{"key":"B88","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2020.01129","article-title":"Use of Allopurinol to Mitigate 6-Mercaptopurine Associated Gastrointestinal Toxicity in Acute Lymphoblastic Leukemia","volume":"10","author":"Conneely","year":"2020","journal-title":"Front Oncol"},{"key":"B89","unstructured":"PharmGKBMethotrexate - Clinical Annotations"},{"key":"B90","doi-asserted-by":"publisher","DOI":"10.1016\/j.nut.2015.06.010","article-title":"\u03c9-3 Fatty Acids as an Adjuvant Therapy Ameliorates Methotrexate-Induced Hepatotoxicity in Children and Adolescents With Acute Lymphoblastic Leukemia: A Randomized Placebo-Controlled Study","volume":"32","author":"Elbarbary","year":"2016","journal-title":"Nutrition"},{"key":"B91","doi-asserted-by":"publisher","DOI":"10.1002\/pbc.22277","article-title":"Ocular Late Effects in Childhood and Adolescent Cancer Survivors: A Report From the Childhood Cancer Survivor Study","volume":"54","author":"Whelan","year":"2010","journal-title":"Pediatr Blood Cancer"},{"key":"B92","doi-asserted-by":"publisher","DOI":"10.1089\/jayao.2020.0064","article-title":"Premature Ocular Aging Features in Childhood Acute Lymphoblastic Leukemia Survivors","volume":"10","author":"Chandrasekaran","year":"2020","journal-title":"J Adolesc Young Adult Oncol"},{"key":"B93","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.20960","article-title":"Body Mass Index in Long-Term Adult Survivors of Childhood Cancer: A Report of the Childhood Cancer Survivor Study","volume":"103","author":"Meacham","year":"2005","journal-title":"Cancer"},{"key":"B94","doi-asserted-by":"publisher","DOI":"10.1542\/peds.2013-3332","article-title":"Obesity in Pediatric ALL Survivors: A Meta-Analysis","volume":"133","author":"Zhang","year":"2014","journal-title":"Pediatrics"},{"key":"B95","doi-asserted-by":"publisher","DOI":"10.1002\/gcc.22701","article-title":"DNA Methylation and Obesity in Survivors of Pediatric Acute Lymphoblastic Leukemia: A Report From the Childhood Cancer Survivor Study","volume":"58","author":"Lupo","year":"2019","journal-title":"Genes Chromosomes Cancer"},{"key":"B96","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1186\/1824-7288-38-4","article-title":"Obesity in Patients With Acute Lymphoblastic Leukemia in Childhood","volume":"38","author":"Iughetti","year":"2012","journal-title":"Ital J Pediatr"},{"key":"B97","doi-asserted-by":"publisher","DOI":"10.1002\/pbc.22237","article-title":"Weight Patterns in Children With Higher Risk ALL: A Report From the Children\u2019s Oncology Group (COG) for CCG 1961","volume":"53","author":"Withycombe","year":"2009","journal-title":"Pediatr Blood Cancer"},{"key":"B98","doi-asserted-by":"publisher","DOI":"10.1002\/1096-911x(200008)35:2<91::aid-mpo1>3.0.co;2-g","article-title":"Changes in Body Mass Index and Prevalence of Overweight in Survivors of Childhood Acute Lymphoblastic Leukemia: Role of Cranial Irradiation","volume":"35","author":"Sklar","year":"2000","journal-title":"Med Pediatr Oncol"},{"key":"B99","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2003.06.131","article-title":"Childhood Cancer Survivor Study. Obesity in Adult Survivors of Childhood Acute Lymphoblastic Leukemia: A Report From the Childhood Cancer Survivor Study","volume":"21","author":"Oeffinger","year":"2003","journal-title":"J Clin Oncol"},{"key":"B100","doi-asserted-by":"publisher","DOI":"10.1002\/pbc.23251","article-title":"Blood Pressure and Body Composition in Long-Term Survivors of Childhood Acute Lymphoblastic Leukemia","volume":"58","author":"Veringa","year":"2012","journal-title":"Pediatr Blood Cancer"},{"key":"B101","doi-asserted-by":"publisher","DOI":"10.1002\/pbc.26344","article-title":"Changes in Body Mass Index in Long-Term Survivors of Childhood Acute Lymphoblastic Leukemia Treated Without Cranial Radiation and With Reduced Glucocorticoid Therapy","volume":"64","author":"Touyz","year":"2017","journal-title":"Pediatr Blood Cancer"},{"key":"B102","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.29153","article-title":"Genetic and Clinical Factors Associated With Obesity Among Adult Survivors of Childhood Cancer: A Report From the St. Jude Lifetime Cohort","volume":"121","author":"Wilson","year":"2015","journal-title":"Cancer"},{"key":"B103","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.33258","article-title":"Genetic Variation in the Body Mass Index of Adult Survivors of Childhood Acute Lymphoblastic Leukemia: A Report From the Childhood Cancer Survivor Study and the St. Jude Lifetime Cohort","volume":"127","author":"Richard","year":"2021","journal-title":"Cancer"},{"key":"B104","doi-asserted-by":"publisher","DOI":"10.1007\/s12185-012-1236-1","article-title":"The Glucocorticoid Receptor Gene Polymorphism N363S Predisposes to More Severe Toxic Side Effects During Pediatric Acute Lymphoblastic Leukemia (ALL) Therapy","volume":"97","author":"Eipel","year":"2013","journal-title":"Int J Hematol"},{"key":"B105","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(13)62674-4","article-title":"DNA Methylation and Body-Mass Index: A Genome-Wide Analysis","volume":"383","author":"Dick","year":"2014","journal-title":"Lancet"},{"key":"B106","doi-asserted-by":"publisher","DOI":"10.1002\/oby.21111","article-title":"Epigenome-Wide Study Identifies Novel Methylation Loci Associated With Body Mass Index and Waist Circumference","volume":"23","author":"Aslibekyan","year":"2015","journal-title":"Obes (Silver Spring)"},{"key":"B107","doi-asserted-by":"publisher","DOI":"10.3324\/haematol.2017.176123","article-title":"Prevalence and Characteristics of Metabolic Syndrome in Adults From the French Childhood Leukemia Survivors\u2019 Cohort: A Comparison With Controls From the French Population","volume":"103","author":"Oudin","year":"2018","journal-title":"Haematologica"},{"key":"B108","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2016.66.6545","article-title":"Endocrine Abnormalities in Aging Survivors of Childhood Cancer: A Report From the Childhood Cancer Survivor Study","volume":"34","author":"Mostoufi-Moab","year":"2016","journal-title":"J Clin Oncol"},{"key":"B109","doi-asserted-by":"publisher","DOI":"10.1002\/hon.2681","article-title":"The Influence of Different Intensity of Treatment on Hormonal Markers of Gonadal Function in Acute Lymphoblastic Leukemia Survivors","volume":"37","author":"Krawczuk-Rybak","year":"2019","journal-title":"Hematol Oncol"},{"key":"B110","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(16)00086-3","article-title":"Pregnancy After Chemotherapy in Male and Female Survivors of Childhood Cancer Treated Between 1970 and 1999: A Report From the Childhood Cancer Survivor Study Cohort","volume":"17","author":"Chow","year":"2016","journal-title":"Lancet Oncol"},{"key":"B111","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2010-01-265751","article-title":"Reimplantation of Cryopreserved Ovarian Tissue From Patients With Acute Lymphoblastic Leukemia Is Potentially Unsafe","volume":"116","author":"Dolmans","year":"2010","journal-title":"Blood"},{"key":"B112","doi-asserted-by":"publisher","DOI":"10.21037\/tau-20-908","article-title":"Fertility Preservation for Pediatric Male Cancer Patients: Illustrating Contemporary and Future Options; a Case Report","volume":"10","author":"Abdelaal","year":"2021","journal-title":"Transl Androl Urol"},{"key":"B113","doi-asserted-by":"publisher","DOI":"10.1002\/pbc.21869","article-title":"Effects of Chemotherapy on Neurocognitive Function in Children With Acute Lymphoblastic Leukemia: A Critical Review of the Literature","volume":"52","author":"Buizer","year":"2009","journal-title":"Pediatr Blood Cancer"},{"key":"B114","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.19.02677","article-title":"Consistent Physical Activity and Future Neurocognitive Problems in Adult Survivors of Childhood Cancers: A Report From the Childhood Cancer Survivor Study","volume":"38","author":"Barlow-Krelina","year":"2020","journal-title":"J Clin Oncol"},{"key":"B115","doi-asserted-by":"publisher","DOI":"10.1093\/jnci\/djaa136","article-title":"Sex-Specific Associations Between Chemotherapy, Chronic Conditions and Neurocognitive Impairment in ALL Survivors: A Report From the Childhood Cancer Survivor Study","volume":"113","author":"van der Plas","year":"2020","journal-title":"J Natl Cancer Inst"},{"key":"B116","doi-asserted-by":"publisher","DOI":"10.1016\/S2215-0366(16)30283-8","article-title":"Cognitive, Behaviour, and Academic Functioning in Adolescent and Young Adult Survivors of Childhood Acute Lymphoblastic Leukaemia: A Report From the Childhood Cancer Survivor Study","volume":"3","author":"Jacola","year":"2016","journal-title":"Lancet Psychiatry"},{"key":"B117","doi-asserted-by":"publisher","DOI":"10.1080\/14737140.2017.1347507","article-title":"New Targeted Therapies for Relapsed Pediatric Lymphoblastic Leukemia","volume":"17","author":"Pierro","year":"2017","journal-title":"Expert Rev Anticancer Ther"}],"container-title":["Frontiers in Oncology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fonc.2021.710163\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,10,16]],"date-time":"2021-10-16T02:03:05Z","timestamp":1634349785000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fonc.2021.710163\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,10,15]]},"references-count":117,"alternative-id":["10.3389\/fonc.2021.710163"],"URL":"https:\/\/doi.org\/10.3389\/fonc.2021.710163","relation":{},"ISSN":["2234-943X"],"issn-type":[{"value":"2234-943X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,10,15]]},"article-number":"710163"}}